Illumina to be forced to discard $8bn unit, says report

Illumina may be forced to offload its cancer treatment unit—valued at $8 billion—by the European Commission (EC), according to sources cited by the Financial Times.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Illumina fined record €432m for completing Grail merger before EC approval

13 July 2023 Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.

Big Pharma

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

More on this story

Big Pharma

Illumina fined record €432m for completing Grail merger before EC approval

13 July 2023 Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.

Big Pharma

Scientist accuses Illumina of long-running trade secrets plot

More on this story

Big Pharma

Illumina fined record €432m for completing Grail merger before EC approval

13 July 2023 Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.

Big Pharma

Scientist accuses Illumina of long-running trade secrets plot